Literature DB >> 11794474

Neurological manifestations of gastrointestinal disorders, with particular reference to the differential diagnosis of multiple sclerosis.

A Ghezzi1, M Zaffaroni.   

Abstract

Neurological manifestations of gastrointestinal disorders are described, with particular reference to those resembling multiple sclerosis (MS) on clinical or MRI grounds. Patients with celiac disease can present cerebellar ataxia, progressive myoclonic ataxia, myelopathy, or cerebral, brainstem and peripheral nerve involvement. Antigliadin antibodies can be found in subjects with neurological dysfunction of unknown cause, particularly in sporadic cerebellar ataxia ("gluten ataxia"). Patients with Whipple's disease can develop mental and psychiatric changes, supranuclear gaze palsy, upper motoneuron signs, hypothalamic dysfunction, cranial nerve abnormalities, seizures, ataxia, myorhythmia and sensory deficits. Neurological manifestations can complicate inflammatory bowel disease (e.g. ulcerative colitis and Crohn's disease) due to vascular or vasculitic mechanisms. Cases with both Crohn's disease and MS or cerebral vasculitis are described. Epilepsy, chronic inflammatory polyneuropathy, muscle involvement and myasthenia gravis are also reported. The central nervous system can be affected in patients with hepatitis C virus (HCV) infection because of vasculitis associated with HCV-related cryoglobulinemia. Mitochondrial neurogastrointestinal encephalopathy (MNGIE) is a disease caused by multiple deletions of mitochondrial DNA. It is characterized by peripheral neuropathy, ophthalmoplegia, deafness, leukoencephalopathy, and gastrointestinal symptoms due to visceral neuropathy. Neurological manifestations can be the consequence of vitamin B1, nicotinamide, vitamin B12, vitamin D, or vitamin E deficiency and from nutritional deficiency states following gastric surgery.

Entities:  

Mesh:

Year:  2001        PMID: 11794474     DOI: 10.1007/s100720100048

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  7 in total

1.  Association of attention-deficit/hyperactivity disorder and celiac disease: a brief report.

Authors:  Helmut Niederhofer
Journal:  Prim Care Companion CNS Disord       Date:  2011

Review 2.  [Diet and multiple sclerosis].

Authors:  S Schwarz; H Leweling
Journal:  Nervenarzt       Date:  2005-02       Impact factor: 1.214

3.  Plasmacytoid dendritic cells in the duodenum of individuals diagnosed with myalgic encephalomyelitis are uniquely immunoreactive to antibodies to human endogenous retroviral proteins.

Authors:  Kenny L De Meirleir; Svetlana F Khaiboullina; Marc Frémont; Jan Hulstaert; Albert A Rizvanov; András Palotás; Vincent C Lombardi
Journal:  In Vivo       Date:  2013 Mar-Apr       Impact factor: 2.155

4.  Cardiac functions assessment in children with celiac disease and its correlation with the degree of mucosal injury: Doppler tissue imaging study.

Authors:  Abeer Fathy; Hany M Abo-Haded; Najat Al-Ahmadi; Marwa M El-Sonbaty
Journal:  Saudi J Gastroenterol       Date:  2016-11       Impact factor: 2.485

5.  Neurological manifestations related to Crohn's disease: a boon for the workforce.

Authors:  Reza Nemati; Somayeh Mehdizadeh; Hooman Salimipour; Ehsan Yaghoubi; Zeinab Alipour; Seyed Masoud Tabib; Majid Assadi
Journal:  Gastroenterol Rep (Oxf)       Date:  2017-09-25

6.  Acute colitis during chronic experimental traumatic brain injury in mice induces dysautonomia and persistent extraintestinal, systemic, and CNS inflammation with exacerbated neurological deficits.

Authors:  Terez Shea-Donohue; Alan I Faden; Marie Hanscom; David J Loane; Taryn Aubretch; Jenna Leser; Kara Molesworth; Nivedita Hedgekar; Rodney M Ritzel; Gelareh Abulwerdi
Journal:  J Neuroinflammation       Date:  2021-01-18       Impact factor: 8.322

Review 7.  Brain-gut axis dysfunction in the pathogenesis of traumatic brain injury.

Authors:  Marie Hanscom; David J Loane; Terez Shea-Donohue
Journal:  J Clin Invest       Date:  2021-06-15       Impact factor: 19.456

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.